Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-6,566
Closed -$65K 233
2023
Q3
$65K Sell
6,566
-1,934
-23% -$26.8K 0.01% 156
2023
Q2
$150K Buy
+8,500
New +$166K 0.03% 151
2022
Q4
$344K Sell
17,221
-2,779
-14% -$64.5K 0.05% 128
2022
Q3
$1.12M Sell
20,000
-10,000
-33% -$663K 0.14% 104
2022
Q2
$1.51M Sell
30,000
-2,500
-8% -$140K 0.14% 123
2022
Q1
$2.56M Hold
32,500
0.19% 153
2021
Q4
$2.67M Hold
32,500
0.22% 166
2021
Q3
$4.44M Buy
32,500
+5,000
+18% +$853K 0.3% 143
2021
Q2
$6.18M Buy
27,500
+17,500
+175% +$3.69M 0.46% 38
2021
Q1
$2.56M Sell
10,000
-3,162
-24% -$694K 0.17% 237
2020
Q4
$2.37M Buy
+13,162
New +$2.89M 0.21% 169

Other funds holding CLNN

Kepos Capital's CLNN Position: Q4 2023 in Review

Kepos Capital sold out of Clene (CLNN) in Q4 2023, closing a stake of 6,566 shares — an estimated $65K sold.

Kepos Capital first reported a position in CLNN in Q4 2020 and held it in 11 quarters. The position peaked at $6.18M in Q2 2021. 44 funds tracked by Wall St. Rank hold CLNN as of Q4 2023.

  • Kepos Capital reported no remaining Clene position as of Q4 2023 after selling out during the quarter.
  • Kepos Capital sold 6,566 Clene shares in Q4 2023, an estimated $65K.
  • Kepos Capital first reported a position in Clene in Q4 2020 and held it in 11 quarters.
  • Kepos Capital's Clene position peaked at $6.18M in Q2 2021.
  • 44 funds tracked by Wall St. Rank held Clene as of Q4 2023.

Based on Kepos Capital's 13F filing for Q4 2023, filed 12 Feb 2024.